Trial Profile
Effectiveness, safety, and controversial points in Sorafenib treatment for advanced hepatocellular carcinoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Mar 2017
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Adverse reactions; Therapeutic Use
- 22 Mar 2017 New trial record